WSTN on Nasdaq

Westin Acquisition Corp

Westin Acquisition Corp is an offices and Clinics of Doctors of Medicine services company.1 Its shares trade on Nasdaq under the symbol WSTN.1

Price unavailable

Last updated Oct 21, 2026.

Overview

$890.4KNet income, fiscal 20262

Compare with another stock.

  • TickerWSTN on Nasdaq1
  • IndustryServices-Offices & Clinics of Doctors of Medicine1
  • HeadquartersE91
  • Incorporated inCayman Islands3
  • Business addressSuite 1165-L 3 Coleman Street #03-24, Singapore, 1798043
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company3

Placement Units”) to the Sponsor at a price of $10.00 per Private Placement Units, generating total gross proceeds of $2,350,000.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2026

47.9%Return on equity2

Financial statements

Every line of the income statement as filed: the last 1 fiscal year, latest first.2

Period ending2026-06-30
Formation costs$11.8K
Administrative fee$478.6K
Total operating expenses$490.3K
Income earned on marketable securities held in Trust Account-$1.4M
Net income(loss)$890.4K

Compare Westin Acquisition Corp with another company

Corporate structure

Westin Acquisition Corp sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of Westin Acquisition Corp

  • Westin Acquisition Corp E9

Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What Westin Acquisition Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Properties, in its own words

We do not own any real estate or other physical properties materially important to our operations. We maintain our principal executive office at Suite 1165-L, 3 Coleman Street #03-24, Singapore 179804.

Item 2 of the 10-K filed Sep 29, 2026.4

Leadership

Who has led Westin Acquisition Corp, and when. Pick a name to see everywhere that person has worked.

Board members and other officers (2)

Timeline

  1. Jul 29, 20268-K Entered a material agreement; Change in control; Regulation FD disclosure11
  2. Dec 31, 20258-K Other events12
  3. Dec 23, 20258-K Other events13
  4. Dec 10, 2025New chief executive Kok Peng Na becomes CEO7
  5. Nov 12, 20258-K Other events14
  6. Nov 6, 20258-K Entered a material agreement; Unregistered sale of shares; Executive or director change15

Filings

41 filings to the SEC since October 2021: 1 annual reports, 5 quarterly reports, 5 major events, 6 insider forms, 9 large holders, 15 other. The latest 20:

  1. Oct 6, 2026SCHEDULE 13G/A EDGAR
  2. Sep 29, 202610-K ANNUAL REPORT EDGAR
  3. Sep 28, 202610-Q/A AMENDMENT NO. 1 TO FORM 10-Q EDGAR
  4. Sep 28, 202610-Q/A AMENDMENT NO. 1 TO FORM 10-Q EDGAR
  5. Jul 29, 2026425 CURRENT REPORT EDGAR
  6. Jul 29, 20268-K CURRENT REPORT EDGAR
  7. Jul 28, 2026SCHEDULE 13D/A EDGAR
  8. Jul 14, 2026SCHEDULE 13G EDGAR
  9. May 15, 202610-Q QUARTERLY REPORT EDGAR
  10. May 14, 2026SCHEDULE 13G/A EDGAR
  11. Mar 6, 2026SCHEDULE 13G EDGAR
  12. Feb 17, 2026SCHEDULE 13G EDGAR
  13. Feb 13, 202610-Q QUARTERLY REPORT EDGAR
  14. Feb 4, 2026SCHEDULE 13G/A EDGAR
  15. Jan 6, 202625-NSE EDGAR
  16. Dec 31, 20258-K CURRENT REPORT EDGAR
  17. Dec 30, 202525-NSE EDGAR
  18. Dec 23, 20258-K CURRENT REPORT EDGAR
  19. Dec 12, 2025SCHEDULE 13D EDGAR
  20. Dec 10, 20253 OWNERSHIP DOCUMENT EDGAR

The 41 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How Westin Acquisition Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARWestin Acquisition Corp1
  • CIK0002076192
  • Employer ID (EIN)00-00000004
  • Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; a shell company4
  • Incorporated inCayman Islands4
  • Fiscal year endsJune 301
  • Industry code (SIC)8011 Services-Offices & Clinics of Doctors of Medicine1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business addressSuite 1165-L 3 Coleman Street #03-24, Singapore, 179804, Singapore1
  • Phone65 9488 44251
  • Shares outstanding7,908,613 as of Sep 25, 20266
  • Public float$0 as of Jun 30, 20262
  • AuditorAudit Alliance LLP, Singapore PCAOB ID 3487; no auditor attestation of internal control over financial reporting4
  • On EDGAR sinceJul 23, 20251
  • Filings41 in all: 3 (6), 8-K (5), SCHEDULE 13G (4), 10-Q (3), S-1/A (3), SCHEDULE 13G/A (3), 10-Q/A (2), 25-NSE (2)1
    All 19 form types

    CORRESP (2), UPLOAD (2), 10-K (1), 424B4 (1), 425 (1), 8-A12B (1), CERT (1), NT 10-Q (1), S-1 (1), SCHEDULE 13D (1), SCHEDULE 13D/A (1)

  • Latest filingsAnnual report (10-K) Sep 29, 2026
    Quarterly report (10-Q) May 15, 2026
    Latest 8-K (8-K) Jul 29, 2026

Securities registered for trading

ClassSymbolExchange
Units, each consisting of one Class A Ordinary Share, par value $0.0001, and one Right entitling the holder to receive one-sixth (1/6)WSTNUNasdaq
Class A Ordinary Shares, par value $0.0001 per shareWSTNNasdaq
Rights to receive one-sixth (1/6) of one Class A Ordinary ShareWSTNRNasdaq

From the cover page of the 10-K filed Sep 29, 2026 (Section 12(b) of the Exchange Act).4

Risk factors and legal proceedings

Legal proceedings

We are not currently a party to any material litigation or other legal proceedings brought against us. We are also not aware of any legal proceeding, investigation or claim, or other legal exposure that has a more than remote possibility of having a material adverse effect on our business, financial condition or results of operations.

The opening of Item 3, Legal Proceedings.4